141 related articles for article (PubMed ID: 21543640)
1. Identification of a potential biomarker for FABP4 inhibition: the power of lipidomics in preclinical drug testing.
Suhre K; Römisch-Margl W; de Angelis MH; Adamski J; Luippold G; Augustin R
J Biomol Screen; 2011 Jun; 16(5):467-75. PubMed ID: 21543640
[TBL] [Abstract][Full Text] [Related]
2. FABP4 inhibition suppresses PPARγ activity and VLDL-induced foam cell formation in IL-4-polarized human macrophages.
Boss M; Kemmerer M; Brüne B; Namgaladze D
Atherosclerosis; 2015 Jun; 240(2):424-30. PubMed ID: 25897794
[TBL] [Abstract][Full Text] [Related]
3. FABP4 inhibitor BMS309403 decreases saturated-fatty-acid-induced endoplasmic reticulum stress-associated inflammation in skeletal muscle by reducing p38 MAPK activation.
Bosquet A; Girona J; Guaita-Esteruelas S; Heras M; Saavedra-García P; Martínez-Micaelo N; Masana L; Rodríguez-Calvo R
Biochim Biophys Acta Mol Cell Biol Lipids; 2018 Jun; 1863(6):604-613. PubMed ID: 29550588
[TBL] [Abstract][Full Text] [Related]
4. Treatment of diabetes and atherosclerosis by inhibiting fatty-acid-binding protein aP2.
Furuhashi M; Tuncman G; Görgün CZ; Makowski L; Atsumi G; Vaillancourt E; Kono K; Babaev VR; Fazio S; Linton MF; Sulsky R; Robl JA; Parker RA; Hotamisligil GS
Nature; 2007 Jun; 447(7147):959-65. PubMed ID: 17554340
[TBL] [Abstract][Full Text] [Related]
5. Small-molecule inhibitors of FABP4/5 ameliorate dyslipidemia but not insulin resistance in mice with diet-induced obesity.
Lan H; Cheng CC; Kowalski TJ; Pang L; Shan L; Chuang CC; Jackson J; Rojas-Triana A; Bober L; Liu L; Voigt J; Orth P; Yang X; Shipps GW; Hedrick JA
J Lipid Res; 2011 Apr; 52(4):646-56. PubMed ID: 21296956
[TBL] [Abstract][Full Text] [Related]
6. Adipocyte fatty acid-binding protein suppresses cardiomyocyte contraction: a new link between obesity and heart disease.
Lamounier-Zepter V; Look C; Alvarez J; Christ T; Ravens U; Schunck WH; Ehrhart-Bornstein M; Bornstein SR; Morano I
Circ Res; 2009 Aug; 105(4):326-34. PubMed ID: 19608978
[TBL] [Abstract][Full Text] [Related]
7. Adipocyte-Induced FABP4 Expression in Ovarian Cancer Cells Promotes Metastasis and Mediates Carboplatin Resistance.
Mukherjee A; Chiang CY; Daifotis HA; Nieman KM; Fahrmann JF; Lastra RR; Romero IL; Fiehn O; Lengyel E
Cancer Res; 2020 Apr; 80(8):1748-1761. PubMed ID: 32054768
[TBL] [Abstract][Full Text] [Related]
8. Fatty acid binding protein 4 (FABP4) as a potential biomarker reflecting myocardial lipid storage in type 2 diabetes.
Rodríguez-Calvo R; Girona J; Rodríguez M; Samino S; Barroso E; de Gonzalo-Calvo D; Guaita-Esteruelas S; Heras M; van der Meer RW; Lamb HJ; Yanes O; Correig X; Llorente-Cortés V; Vázquez-Carrera M; Masana L
Metabolism; 2019 Jul; 96():12-21. PubMed ID: 30999003
[TBL] [Abstract][Full Text] [Related]
9. Local Production of Fatty Acid-Binding Protein 4 in Epicardial/Perivascular Fat and Macrophages Is Linked to Coronary Atherosclerosis.
Furuhashi M; Fuseya T; Murata M; Hoshina K; Ishimura S; Mita T; Watanabe Y; Omori A; Matsumoto M; Sugaya T; Oikawa T; Nishida J; Kokubu N; Tanaka M; Moniwa N; Yoshida H; Sawada N; Shimamoto K; Miura T
Arterioscler Thromb Vasc Biol; 2016 May; 36(5):825-34. PubMed ID: 27013610
[TBL] [Abstract][Full Text] [Related]
10. Expression and function of fatty acid-binding protein 4 during mouse decidualization.
Tian Z; Zhao ZA; Liang XH; Zhang XH; Sha AG; Zhang ZR; Yu YS; Yang ZM
Fertil Steril; 2011 Jun; 95(8):2749-52.e1-5. PubMed ID: 21704217
[TBL] [Abstract][Full Text] [Related]
11. FABP4 blocker attenuates colonic hypomotility and modulates white adipose tissue-derived hormone levels in mouse models mimicking constipation-predominant IBS.
Mosińska P; Jacenik D; Sałaga M; Wasilewski A; Cygankiewicz A; Sibaev A; Mokrowiecka A; Małecka-Panas E; Pintelon I; Storr M; Timmermans JP; Krajewska WM; Fichna J
Neurogastroenterol Motil; 2018 May; 30(5):e13272. PubMed ID: 29266569
[TBL] [Abstract][Full Text] [Related]
12. Discovery of highly selective inhibitors of human fatty acid binding protein 4 (FABP4) by virtual screening.
Cai H; Yan G; Zhang X; Gorbenko O; Wang H; Zhu W
Bioorg Med Chem Lett; 2010 Jun; 20(12):3675-9. PubMed ID: 20471252
[TBL] [Abstract][Full Text] [Related]
13. Metformin reduces lipid accumulation in macrophages by inhibiting FOXO1-mediated transcription of fatty acid-binding protein 4.
Song J; Ren P; Zhang L; Wang XL; Chen L; Shen YH
Biochem Biophys Res Commun; 2010 Feb; 393(1):89-94. PubMed ID: 20102700
[TBL] [Abstract][Full Text] [Related]
14. Fatty acid binding protein 4 regulates intracellular lipid accumulation in human trophoblasts.
Scifres CM; Chen B; Nelson DM; Sadovsky Y
J Clin Endocrinol Metab; 2011 Jul; 96(7):E1083-91. PubMed ID: 21525163
[TBL] [Abstract][Full Text] [Related]
15. Regulative effect of maternal serum fatty acid-binding protein 4 on insulin resistance and the development of gestational diabetes mellitus.
Duan B; Li Y; Dong K; Sun Y; Ma A; Yang X
Prostaglandins Leukot Essent Fatty Acids; 2020 Dec; 163():102213. PubMed ID: 33260074
[TBL] [Abstract][Full Text] [Related]
16. Effect of peroxisome proliferator-activated receptor-alpha ligands in the interaction between adipocytes and macrophages in obese adipose tissue.
Toyoda T; Kamei Y; Kato H; Sugita S; Takeya M; Suganami T; Ogawa Y
Obesity (Silver Spring); 2008 Jun; 16(6):1199-207. PubMed ID: 18356826
[TBL] [Abstract][Full Text] [Related]
17. Active spice-derived components can inhibit inflammatory responses of adipose tissue in obesity by suppressing inflammatory actions of macrophages and release of monocyte chemoattractant protein-1 from adipocytes.
Woo HM; Kang JH; Kawada T; Yoo H; Sung MK; Yu R
Life Sci; 2007 Feb; 80(10):926-31. PubMed ID: 17196622
[TBL] [Abstract][Full Text] [Related]
18. Macrophage-derived AIM is endocytosed into adipocytes and decreases lipid droplets via inhibition of fatty acid synthase activity.
Kurokawa J; Arai S; Nakashima K; Nagano H; Nishijima A; Miyata K; Ose R; Mori M; Kubota N; Kadowaki T; Oike Y; Koga H; Febbraio M; Iwanaga T; Miyazaki T
Cell Metab; 2010 Jun; 11(6):479-92. PubMed ID: 20519120
[TBL] [Abstract][Full Text] [Related]
19. Cellular growth and tube formation of HTR8/SVneo trophoblast: effects of exogenously added fatty acid-binding protein-4 and its inhibitor.
Basak S; Sarkar A; Mathapati S; Duttaroy AK
Mol Cell Biochem; 2018 Jan; 437(1-2):55-64. PubMed ID: 28620819
[TBL] [Abstract][Full Text] [Related]
20. Small molecule inhibitors of human adipocyte fatty acid binding protein (FABP4).
Zhang M; Zhu W; Li Y
Med Chem; 2014 Jun; 10(4):339-47. PubMed ID: 24024500
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
